Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
Titel:
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
Auteur:
Levin, Johannes Sing, Nand Melbourne, Sue Morgan, Amber Mariner, Carla Spillantini, Maria Grazia Wegrzynowicz, Michal Dalley, Jeffrey W. Langer, Simon Ryazanov, Sergey Leonov, Andrei Griesinger, Christian Schmidt, Felix Weckbecker, Daniel Prager, Kai Matthias, Torsten Giese, Armin